This week’s plant medicine newsletter covers CBD’s potential for neuroinflammation and Alzheimer’s disease, new research on CBD for chemotherapy-induced pain, oral health, and acne, plus updates on medical cannabis in the workplace and the DEA’s rescheduling proceedings.
Noteworthy Read
Can CBD Play a Role in Treating Alzheimer’s Disease? (Dr. Andrew Weil)
Dr. Andrew Weil reviews emerging evidence that CBD may have relevance for Alzheimer’s disease, particularly through its effects on neuroinflammation and brain immune activity. The piece looks at CBD within the broader conversation about how cannabinoids may help protect the aging brain and support new approaches to neurodegenerative disease.
Read the full article
Note: Project CBD interviewed Dr. Weil in 2023 on cannabis and integrative medicine. Read the interview here.
View more in CBD
More Noteworthy Reading
Medical Cannabis Cuts Employee Sick Days (Inc.)
Inc. reports on research linking medical cannabis access to fewer health-related work absences, with employee sick days falling by about 7% in states with medical cannabis laws. The findings suggest legal access may help some workers better manage chronic symptoms and remain active in the workforce.
US Tobacco Giant Is Behind Planned Takeover of Biggest Licensed Dutch Cannabis Grower (Cannabis Law Report)
Cannabis Law Report highlights a planned takeover involving the Netherlands’ largest licensed cannabis grower and a major U.S. tobacco company. The story underscores the growing interest of legacy tobacco firms in regulated cannabis markets as medical and adult-use systems mature.
DEA Argues in Favor of Moving Cannabis to Schedule III (Ganjapreneur)
The DEA has spent years dragging its feet on cannabis rescheduling, and now it’s standing in its own courtroom, calling its own witnesses, and arguing that the rule should actually go into effect.
Research Round-Up
CBD Attenuates Chemo-Induced Peripheral Neuropathic Pain (PubMed)
New research suggests CBD may reduce chemotherapy-induced peripheral neuropathic pain, a common and difficult side effect of cancer treatment. The study connects CBD’s pain-modulating effects with endocannabinoid and lipid signaling pathways, adding to interest in cannabinoids as supportive tools in oncology care.
Read more
View more in Endocannabinoid System
CBD Mouthwash Effective Without Damaging Enamel (Marijuana Herald)
A new study found that a low-concentration CBD mouthwash helped control dental biofilm without damaging enamel properties. The findings point to CBD’s potential in oral health formulations, especially as researchers explore alternatives to conventional antimicrobial ingredients.
CBD-Rich Cannabis Extracts and CBD Isolate for Acne (Molecules)
A new review examines CBD-rich cannabis extracts and isolated CBD as potential tools for managing inflammatory acne. The authors highlight CBD’s anti-inflammatory and sebum-regulating properties, connecting cannabinoid science with a growing interest in plant-derived dermatology.
A heartfelt thank you to all of the CBD brands whose generous support allows Project CBD to shine a light on the latest plant medicine research and bring these stories to our readers each week.
